Connect with us

World

Personal Injury Lawyer Richard Console Helping Those Impacted By Popular Diabetes Drug Metformin

mm

Published

on

Doctors have prescribed Metformin to more than 120 million patients worldwide to manage diabetes and other health conditions. Although the FDA has only approved Metformin for the treatment of type-2 diabetes, the drug is widely used off-label to treat many other conditions — including prediabetes, gestational diabetes, polycystic ovary syndrome (PCOS), fertility problems and more.

In June 2020, a recall of the drug was announced by drugmaker Apotex, after finding certain batches containing possible high levels of NDMA, a known animal carcinogen which is also believed to cause cancer in humans. Due to Metformin often being prescribed for off-label use, this means that even a greater number of patients have suffered harm from it. 

Metformin Recall

In May 2020, the FDA identified five pharmaceutical companies that produced batches of Metformin that, according to the agency’s laboratory tests, contained unacceptably high levels of NDMA. The contaminated lots of Metformin that have been recalled are only the extended-release tablets.

As of early June 2020, four of the five pharmaceutical companies that produced contaminated batches of Metformin have initiated recalls of 28 products:

  1. Apotex, which recalled all lots of its metformin products with the NDC (National Drug Code) identification number 60505-0260-1
  2. Actavis Generics (part of Teva Pharmaceuticals), which recalled 14 items with various NDC and lot numbers
  3. Amneal Pharmaceuticals, which recalled all lots of 12 metformin products with various NDC numbers
  4. Time-Cap Labs, Inc. (part of Marksans Pharma), which recalled just 1 lot of metformin (lot number XP9004)

Metformin, NDMA and Cancer

While NDMA is dangerous and a known animal carcinogen and probable human carcinogen, it is fairly common and can be found in everything from air, soil, water and consumer products like cured meat, tobacco and shampoo, according to Everyday Health. Because exposure to very small amounts of NDMA is unavoidable, the FDA set a maximum “reasonably safe” daily intake of 96 nanograms, the equivalent to one billionth of a gram.

Consuming more than the maximum daily amount could raise your risk for cancer. The FDA released a public statement advising the public, “Although there are no reports of NDMA causing cancer in humans, it is reasonable to expect that exposure to NDMA by eating, drinking or breathing could cause cancer in humans.”

According to online pharmacy Valisure, who conducted independent laboratory testing of Metformin, several of the affected batches of the drug contained more than ten times that amount. The batches that performed the worst testing for NDMA had 16 times the recommended amount.

“Imagine ingesting 16 times what’s recommended as the maximum exposure — on top of whatever environmental or dietary exposures you might have —every single day, for years, decades, or even a lifetime,” stated personal injury attorney, Richard Console

The cancer-causing impact of NDMA is believed to be cumulative. “It’s easy to see how a patient exposed to the carcinogen through their diabetes medication could continue to unknowingly stack their cancer risk higher as the year’s pass,” empathizes Console.

Over the years, a myriad of laboratory research on animals and human observation studies those who have been exposed to NDMA. Findings have shown that the chemical can cause or contribute to developing several different forms of cancers. Possible overexposure to the powerful carcinogen has been linked to more than a dozen types of cancer, including the following:

  • Prostate Cancer
  • Lower Esophageal Cancer
  • Non-Hodgkin’s Lymphoma
  • Leukemia
  • Multiple Myeloma
  • Colon Cancer
  • Stomach Cancer
  • Intestinal Cancer
  • Pancreatic Cancer

What You Should Do

First, call your doctor if you have recently been taking Metformin or if you were prescribed it in the past. Do not stop taking the drug without first speaking to a medical professional, as it could cause side effects. The sooner you reach out to your physician to discuss your risks and options, the better.

Once you have spoken to your doctor, contact an attorney. Because cancer often presents itself without an obvious origin, determining whether it’s likely that NDMA caused you to develop cancer, it may be best to reach out to a Metformin injury lawsuit attorney right away. When working to determine a substantial case, they will explore questions like:

  • How long and at what dosage have you been taking Metformin?
  • When were you diagnosed with cancer?
  • In general, is the type of cancer you developed common or rare? What about for patients in your age group, specifically?
  • What risk factors did you already have for cancer you developed?
  • What stage was or is your cancer? Has it seemed to progress more quickly than expected?
  • Has a doctor suggested there may be a link between the medication you took and your cancer? What might a medical expert think?

Additionally, for those that used Metformin prior to developing cancer and developed a rare cancer for which they didn’t have risk factors, there’s a strong chance that NDMA from diabetes medication could be to blame. Those who believe they may have developed cancer after taking Metformin may be eligible for a mass tort claim, which may make getting the compensation you deserve easier.

“When you are taking a medication that is supposed to help you, it’s hard to accept that it could have caused more harm than good,” says Console. “A lawsuit cannot give you back what you have lost, but personal injury attorneys are there to be your advocate and get the justice and compensation to minimize the overwhelming financial burden of a cancer battle.”

Richard P. Console, Jr. is the founder of Console and Associates, PC. He opened his law firm to serve one vital purpose: to help the victims of accidents and injuries at the time when they need help the most. Mr. Console is licensed to practice law in Pennsylvania, New Jersey, and New York. Since 1994, he has represented over 7,000 clients and has achieved a record of success getting clients every dollar of compensation they deserve.

If you or anyone you know has developed cancer following regular use of Metformin, please speak with a Metformin lawsuit attorney right away.

Jenny is one of the oldest contributors of Bigtime Daily with a unique perspective of the world events. She aims to empower the readers with delivery of apt factual analysis of various news pieces from around the World.

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

World

Turkish Textile Giant Sun Textile Solution Proposal for Drought

mm

Published

on

While the World Health Organization (WHO) and the United Nations (UN) are seeking solutions to combat drought through various projects, Ekoten Textile, a subsidiary of Turkey’s textile giant Sun Textile, has developed a groundbreaking project in collaboration with a technology startup to minimize the intensive water consumption in the textile industry. This pioneering project, the first of its kind globally, will enable the recycling and reuse of up to 90% of the water used in textile production.

Drought is one of the most pressing issues facing the world today. According to WHO data, 40% of the global population is struggling with water scarcity. By 2030, up to 700 million people could be forced to migrate due to drought. The unconscious use of water in global production processes plays a significant role in the rapid depletion of clean water resources.

The textile industry is one of the sectors with the highest water consumption. In Turkey, while the food industry consumes 22% of the water used for industrial purposes, the textile sector follows closely with 18%. For instance, producing an average of 40 tons of products daily requires 2,500 tons of water, equivalent to the daily water consumption of approximately 10,000 people.

CLEAN WATER RESOURCES FOR HUNDREDS OF THOUSANDS OF PEOPLE EVERY DAY!

In textile production, where clean water resources are heavily consumed, the innovative success of the Turkish company stands out as a global best practice. This initiative will shape the future of the industry. The wastewater recycling project, developed through intensive R&D efforts, will ensure that over 90% of the required water is sourced from recycled supplies.

The reuse of wastewater in production will transform the fate of countries operating in the textile sector. By preventing the use of clean water resources for textile production, this project will free up clean water sources that can meet the daily needs of hundreds of thousands of people.

R&D ACTIVITIES IN 38 COUNTRIES WITH 380 PARTNERS!

Sun Textile places great emphasis on R&D activities, conducting research and development efforts with 380 partners across 38 countries. Sun Textile and its subsidiary Ekoten Textile export nearly 90% of their production, solidifying their identity as a leading exporter. The company ships products to numerous destinations worldwide, including European countries, the UK, and the US. Sun Textile, the leading ready-to-wear exporter in the Aegean Region, achieved a consolidated turnover of 250 million euros in the third quarter of 2024, continuing its active growth trajectory.

OFFERING CUSTOM DESIGNS TO CUSTOMERS

Sun Textile provides its own designed collections to leading brands in Europe and the UK. Ekoten Textile, its subsidiary, is among the most respected knitted fabric manufacturers in Turkey and Europe. 

With a dedicated sales team for each major customer group and five design offices in three different countries, Sun Textile creates designs tailored to its customers’ needs. Its largest clients include the Inditex Group, H&M, Jimmy Key, Tesco, Kiabi, Marks & Spencer, and Next.

Sun Textile also extends its sustainability approach to social responsibility, notably for its high ratio of female employees. The company, which went public in 2022, is also listed in dividend indexes.

Continue Reading

Trending